AI That Actually Works in Pharma R&D
Move beyond pilots and proofs-of-concept to AI systems that hold up in production — controlled, trusted, and adopted across your organization.
Built for GxP. Designed to hold up under audit.
Most AI initiatives don’t fail loudly. They fade quietly — through lack of trust, weak adoption, and systems no one actually uses.
In pharma R&D, successful AI systems are built on three things:
Control
Systems behave predictably because data, tools, and workflows are intentionally designed.
Trust
Outputs are grounded, traceable, and defensible under audit.
Adoption
Teams actually use the system because it’s reliable and aligned with how they work.
Control, trust, and adoption aren’t abstract concepts — they show up in very specific ways.
Consistency starts with control
Without control, systems become unpredictable — driven by inconsistent data, weak retrieval, or poorly defined workflows.
If no one trusts it, no one uses it
Without trust, outputs aren’t used—no matter how impressive they look in a demo.
Where ROI lives or dies
Without adoption, there is no ROI. Systems only create value when they align with how teams actually work.
Immediate Traction (Low Risk, High Visibility)
Internal knowledge retrieval
Literature review and synthesis
Document drafting (with human review)
Clinical Development (High Value, Higher Complexity)
Protocol design support
Patient matching and cohort identification
Site selection and feasibility
Safety & Pharmacovigilance (Operational Leverage)
Case intake and triage
Signal detection support
Narrative generation
Regulatory & Submission
Document drafting (CSR, IND, NDA)
Traceability across documents
Consistency and quality checks
Cross-Functional Knowledge Work
Meeting and decision support
Internal knowledge synthesis
Cross-team visibility
Portfolio & Decision Support
Scenario analysis
Risk identification and mitigation
Program-level insights
Common Pattern - All Areas
Unstructured data → structured insight
Human-in-the-loop decisions
Workflow acceleration
The technology matters — but operational alignment, trust, and workflow integration determine whether these systems create lasting value.
AI systems rarely fail because the model isn’t capable.
They fail because the surrounding ecosystem — data, workflows, governance, evaluation, and organizational alignment — wasn’t designed for production reality.
Weak data foundations
Poor data quality and fragmented knowledge sources create confident but unreliable outputs.
Tool-first thinking
Deploying AI without redesigning workflows rarely creates lasting value.
Organizational misalignment
When business, IT, and compliance move independently, initiatives stall or fragment into shadow AI.
Governance gaps
Without clear controls, organizations introduce compliance, security, and operational risk.
Lack of trust
Inconsistent or untraceable outputs quickly reduce adoption.
The organizations seeing meaningful value from AI are approaching it as a systems and workflow transformation challenge — not simply a technology rollout.
Founder: Centrific Ai
I’ve spent more than 25 years delivering enterprise systems in global pharma R&D across clinical, regulatory, safety, and operational domains.
Today, I focus on helping organizations navigate the realities of AI adoption in regulated environments — governance, trust, workflow integration, and systems designed to hold up under real-world scrutiny.
My work sits at the intersection of:
AI architecture
enterprise systems delivery
operational understanding of Pharma R&D
MIT Sloan School of Management — AI in Pharma & Biotechnology
Johns Hopkins Whiting School of Engineering — Agentic AI Development